샘플 요청 목록

 카트 문의
시장보고서
상품코드
1885941

세계의 불임 치료 서비스 시장

Fertility Services
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 불임 치료 서비스 시장은 2030년까지 1,242억 달러에 달할 전망

불임 치료 서비스 세계 시장은 2024년에 538억 달러로 추정되며, 2024년부터 2030년까지의 분석 기간 동안 CAGR 15.0%로 성장하여 2030년까지 1,242억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석 대상으로 한 부문 중 하나인 신선 비제공자는 16.1%의 CAGR을 기록하며 분석 기간 종료까지 753억 달러에 달할 것으로 예측됩니다. 한편 동결 비제공자 부문의 성장률은 분석 기간 동안 13.7%의 CAGR로 추정됩니다.

미국 시장은 136억 달러로 추정되는 한편 중국은 19.4%의 CAGR로 성장할 것으로 예측됩니다

미국의 불임 치료 서비스 시장은 2024년에 136억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년까지의 분석 기간 동안 19.4%의 CAGR로 증가하여 2030년까지 317억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다가 있으며, 분석 기간 동안에 각각 10.1%, 12.5%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 11.3%의 CAGR로 성장할 것으로 예측됩니다.

세계의 불임 치료 서비스 시장 - 주요 동향과 촉진요인 개요

불임 치료 서비스는 생식 의료와 가족계획에 어떤 변화를 가져오고 있을까?

불임 치료 서비스는 임신에 어려움을 겪는 개인과 부부에게 고도의 의료적 개입과 개별화된 치료를 제공함으로써 생식 의료와 가족 계획을 변화시키고 있습니다. 불임 치료에 대한 인식과 수용도가 높아지면서 체외수정(IVF), 난자 동결, 유전자 검사 등 보조생식술(ART)의 발전은 전 세계 수백만 명의 사람들에게 희망을 가져다주고 있습니다. 불임 치료 서비스에는 불임 진단 및 치료, 가족계획 지원, 생식 의료 향상을 위한 다양한 치료법이 포함됩니다. 이러한 서비스는 현대 의료에서 필수적인 요소로 자리 잡고 있으며, 나이, 건강 상태, 기타 요인에 관계없이 개인과 부부가 부모가 되는 꿈을 실현할 수 있도록 돕고 있습니다.

최근 출산연령 하향, 생활습관 요인, 불임율 상승 등 사회적 변화로 인해 불임치료 서비스에 대한 수요가 증가하고 있습니다. 현재 불임클리닉에서는 불임 평가 및 호르몬 치료부터 최첨단 ART 시술까지 다양한 서비스를 제공하고 있습니다. 특히 미래의 임신을 위해 생식능력을 보존하고자 하는 여성들 사이에서 난자 동결의 보급이 두드러진 추세입니다. 이러한 불임 치료 서비스의 확대는 개인이 자신의 생식 건강을 관리할 수 있는 권한을 부여할 뿐만 아니라, 특히 동성 커플, 미혼모, 생식 건강 문제에 직면한 사람들에게 가족계획에 대한 접근성을 높이고 종합적인 접근을 가능하게 합니다. 불임 치료 기술이 발전하고 사회적 수용도가 높아짐에 따라 이러한 서비스는 사람들의 가족 계획 방식에 변화를 가져오는 역할을 하고 있습니다.

불임 치료 서비스가 생식 문제를 해결하고 가족 계획의 선택권을 확대하는 데 필수적인 이유는 무엇일까?

불임 치료 서비스가 생식 문제 해결과 가족 계획 옵션 확대에 필수적인 이유는 자연 임신이 어려운 개인과 부부에게 의학적 해결책을 제공하기 때문입니다. 전 세계적으로 불임의 영향을 받는 부부가 약 10-15%에 달하는 가운데, 불임 치료 서비스는 임신을 방해하는 근본적인 원인을 진단하고 치료함으로써 희망과 지원을 제공합니다. 노화, 호르몬 불균형, 유전적 요인, 생활습관 문제 등 불임의 원인은 다양하지만 그 과정은 몸과 마음에 큰 부담이 될 수 있습니다. 체외수정(IVF), 인공수정(IUI), 난자 및 정자 제공과 같은 불임 치료를 통해 이러한 장벽을 극복하고 임신을 달성할 수 있습니다.

불임 치료 서비스는 불임에 직면하지 않은 가족 계획 옵션을 원하는 사람들에게도 중요합니다. 개인적인 사정이나 경력상의 이유로 출산을 늦추기로 선택한 여성은 난자 동결을 이용할 수 있습니다. 이를 통해 최적의 시기에 난자를 저장하고, 향후 임신 계획에 유연성을 부여할 수 있습니다. 또한, 불임 치료 서비스는 LGBTQ+, 커플, 싱글 부모들에게도 중요한 선택지를 제공합니다. 가족을 만들기 위해 난자 제공, 정자 제공 또는 대리모 출산이 필요한 경우, 이러한 서비스는 생물학적 제약이나 전통적인 가족 형태에 대한 친권 제한 없이 보다 포괄적이고 다양한 양육 경로를 가능하게 합니다.

불임 치료 서비스의 또 다른 중요한 역할은 다낭성난소증후군(PCOS), 자궁내막증, 정자수 감소, 운동성 저하 등 남성 불임과 같은 질환에 대한 대응에 있습니다. 이러한 질환은 진단과 치료가 이루어지지 않은 채 방치되는 경우가 많지만, 불임 클리닉에서는 임신 가능성을 높이기 위한 표적화된 치료와 개입을 제공합니다. 또한, 유전자 스크리닝과 착상 전 유전자 검사(PGT)의 발전으로 임신 전에 유전 질환을 확인할 수 있게 되어 부모와 아기 모두에게 더 건강한 결과를 보장할 수 있게 되었습니다. 이러한 종합적인 불임 치료 접근법을 통해 더 많은 사람들이 복잡한 생식 문제를 해결하고, 이전에는 불가능했던 방식으로 가족 형성의 선택권을 넓힐 수 있도록 돕고 있습니다.

생식 의료의 불임 치료 서비스 적용 범위와 혁신의 확대는?

불임 치료 서비스의 적용 범위와 혁신은 의료 기술, 유전학, 맞춤형 생식 의료의 발전에 힘입어 빠르게 확대되고 있습니다. 불임 치료 서비스에서 가장 중요한 발전 중 하나는 체외수정(IVF)의 보급입니다. 이는 부부와 개인이 불임에 대처하는 방식에 혁신을 가져왔습니다. IVF는 체외에서 난자를 수정시킨 후 배아를 자궁에 이식하는 시술입니다. 기술의 발전과 함께 체외수정 성공률이 높아지면서 불임 치료에서 가장 효과적인 치료법 중 하나로 자리 잡았습니다. 타임랩스 이미징과 배아 모니터링 시스템 등의 혁신으로 배아 배양사는 배아 발달을 보다 정밀하게 평가할 수 있게 되어 착상 및 임신 성공 확률을 높일 수 있게 되었습니다.

난자 및 정자 동결 기술도 크게 발전하여 생식 능력 보존의 기회를 확대하고 있습니다. 유리화법을 포함한 동결보존 기술로 난자나 정자의 생존율을 높인 동결이 가능해져 개인에게 부모가 되는 시기를 늦출 수 있는 선택권을 제공하고 있습니다. 이는 화학요법으로 인한 불임의 위험에 직면한 암 환자나 개인적, 직업적 이유로 생식능력을 보존하고자 하는 여성에게 특히 중요합니다. 또한, 정자 채취 기술의 발전으로 정자 수가 적은 남성이나 기타 불임 문제를 가진 남성도 보조생식술로 임신을 할 수 있게 되었습니다.

불임 치료 서비스의 또 다른 획기적인 혁신은 착상 전 유전자 검사(PGT)입니다. 이를 통해 착상 전 배아의 유전자 스크리닝이 가능합니다. PGT는 염색체 이상, 낭포성섬유증, 겸상 적혈구 빈혈, 헌팅턴병과 같은 유전성 질환을 검출할 수 있어 체외수정(IVF) 시 건강한 배아만 이식할 수 있도록 보장합니다. 이 기술은 임신 성공률을 높일 뿐만 아니라 유산 위험과 자녀의 유전적 질병 위험을 감소시킵니다. 현재 유전 상담은 불임 치료 서비스의 필수적인 요소로 자리 잡았으며, 부부가 자신의 유전적 구성에 따라 생식 관련 선택에 대한 정보에 입각한 결정을 내릴 수 있도록 돕고 있습니다.

이러한 기술적 발전과 더불어 불임 치료 서비스는 생식 건강에 대한 보다 종합적인 접근 방식으로 확대되고 있습니다. 불임 치료에서 정서적, 신체적, 심리적 측면에 대한 대응의 중요성을 인식하고 불임 코칭, 영양 지도, 정신건강 상담, 침술 등의 지원 서비스를 제공하는 클리닉이 증가하고 있습니다. 불임클리닉에서도 디지털 헬스 툴의 도입이 활발히 이루어지고 있으며, 원격의료 상담, 배란주기 관리 앱, 원격 모니터링이 보편화되고 있습니다. 이러한 환자 중심 치료로의 전환을 통해 복잡한 불임 치료 과정을 더 많은 지원과 편의성을 가지고 진행할 수 있게 되었습니다.

불임 치료 서비스의 또 다른 혁신 분야는 인공지능(AI)과 머신러닝의 활용 확대입니다. AI 기반 시스템은 환자 정보, 배아 발달 상태, 치료 결과 등 대규모 데이터세트를 분석하여 의사가 불임 치료 계획에 대해 보다 정확한 판단을 내릴 수 있도록 돕고 있습니다. 예를 들어, 환자의 병력, 유전자 정보, 배아의 질에 따라 체외수정(IVF) 주기의 성공률을 예측할 수 있게 되어 보다 개인화된 효과적인 치료 전략을 수립할 수 있게 되었습니다. 이러한 혁신은 불임 치료의 효율성과 접근성을 높이고 성공률을 향상시켜 가족을 이루고자 하는 개인과 부부에게 새로운 가능성을 열어주고 있습니다.

불임 치료 서비스 시장의 성장을 이끄는 요인은 무엇일까?

불임 증가, 출산 연령의 고령화, 생식 의료 기술의 발전, 불임 치료에 대한 사회적 수용성 향상 등 몇 가지 주요 요인이 불임 치료 서비스 시장의 성장을 주도하고 있습니다. 주요 촉진요인 중 하나는 남성과 여성 모두에게 영향을 미치는 불임의 세계 발생률 증가입니다. 생활습관의 변화, 환경오염물질, 스트레스, 비만, 다낭성난소증후군(PCOS) 등의 질환 등의 요인이 불임률 상승에 기여하고 있습니다. 자연 임신이 어려운 사람들이 늘어나면서 체외수정(IVF), 인공수정(IUI), 가임력 보존 등의 치료법이 보편화되면서 불임 치료 서비스에 대한 수요는 계속 증가하고 있습니다.

불임 치료 서비스 시장의 성장에 기여하는 또 다른 중요한 요인은 출산 연령의 고령화 추세입니다. 경력, 교육, 개인적 목표를 우선시하는 여성들이 늘어나면서 많은 사람들이 인생 후반에 아이를 갖는 것을 선택하고 있습니다. 그러나 특히 여성에게 있어 나이는 불임 치료에 있어 중요한 요소이며, 나이가 들수록 임신 능력은 감소합니다. 난자 동결 및 체외수정(IVF)을 포함한 불임 치료 서비스는 임신 능력을 유지하고, 임신을 원하는 여성에게 솔루션을 제공하며, 이러한 서비스에 대한 수요 증가로 이어지고 있습니다. 또한, 재혼과 스텝패밀리의 증가에 따라 고령의 개인이나 부부가 함께 아이를 갖기 위해 불임치료 서비스를 이용하는 사례도 증가하고 있어 시장 성장을 더욱 촉진하고 있습니다.

생식 의료 기술의 발전도 불임 치료 서비스 시장 확대에 중요한 역할을 하고 있습니다. 착상 전 유전자 검사(PGT), 타임랩스 배아 관찰, 동결보존 기술 등의 혁신으로 불임 치료의 성공률이 향상되어 생식 보조를 원하는 개인과 부부에게 더욱 매력적인 선택이 되고 있습니다. 불임 클리닉에서 AI와 머신러닝의 통합은 보다 개인화된 치료 제공과 치료 전략의 최적화를 통해 치료 결과를 더욱 향상시키고 있습니다. 이러한 기술 발전으로 불임 치료는 더욱 효과적이고 접근하기 쉬워졌으며, 더 많은 사람들이 불임 치료 옵션을 고려하도록 유도하고 있습니다.

불임치료에 대한 사회적 수용성이 높아지는 것도 시장 성장을 이끄는 주요 요인입니다. 한때 금기시되고 편견의 대상이었던 불임 치료는 특히 선진국에서 널리 받아들여지고 긍정적으로 받아들여지고 있습니다. 유명인이나 연예인들이 자신의 불임 치료 경험을 공개적으로 이야기함으로써 불임에 대한 편견이 줄어들고 더 많은 사람들이 불임 치료 서비스를 이용하도록 유도하고 있습니다. 또한, 동성결혼의 법적 승인, 대리모 및 기증자 프로그램 이용 가능성과 같은 법적, 사회적 발전으로 인해 LGBTQ+와 미혼부모가 가족을 꾸릴 수 있는 새로운 길이 열리고 있습니다. 이러한 치료법이 보다 친숙하고 보편화됨에 따라 불임 치료 서비스 시장은 계속 확대되고 있습니다.

정부의 불임치료 지원 강화와 의료보험 적용 범위 확대도 시장 성장을 견인하고 있습니다. 많은 국가에서 보험회사나 의료제도가 체외수정(IVF)과 같은 불임 치료 비용의 일부를 부담하기 시작하면서, 보다 많은 사람들이 치료 비용을 부담할 수 있게 되었습니다. 생식 건강을 증진하고 불임 치료에 대한 재정적 지원을 제공하는 정부의 노력도 이러한 서비스에 대한 접근성 향상에 기여하고 있습니다. 저출산 지역에서는 정부가 인구 증가를 촉진하기 위한 국가적 노력의 일환으로 불임 치료에 투자하고 있으며, 이는 시장 확대에 더욱 기여하고 있습니다.

결론적으로, 불임을 극복하거나, 부모가 되는 시기를 늦추거나, 비 전통적인 가족 형성 옵션을 추구하기 위해 더 많은 개인과 부부가 생식 지원을 요청함에 따라 불임 치료 서비스 시장은 크게 성장할 것으로 예상됩니다. 생식 기술의 발전, 사회적 수용성의 증가, 불임 치료의 접근성 확대에 따라 이 산업은 사람들이 부모가 되는 꿈을 실현하는 데 있어 그 어느 때보다 중요한 역할을 하게 될 것입니다. 불임 치료가 계속 발전함에 따라 보다 포괄적이고 효과적이며 개별화된 치료가 제공되어 전 세계 생식 의료 및 가족계획 분야에 혁명을 가져올 것입니다.

부문:

부문(신선 비제공자, 동결 비제공자, 난자/배아은행, 신선 제공자, 동결 제공자), 최종사용자(불임클리닉, 병원, 수술 센터, 임상연구기관)

조사 대상 기업 예시

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업별 SLM을 쿼리하는 일반적인 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 동영상 전사, 블로그, 검색 엔진 조사, 그리고 방대한 양의 기업 데이터, 제품 및 서비스 데이터, 시장 데이터 등이 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁 변화를 예측하면서 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.12.18

Global Fertility Services Market to Reach US$124.2 Billion by 2030

The global market for Fertility Services estimated at US$53.8 Billion in the year 2024, is expected to reach US$124.2 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2024-2030. Fresh Non-Donor, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of the analysis period. Growth in the Frozen Non-Donor segment is estimated at 13.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.6 Billion While China is Forecast to Grow at 19.4% CAGR

The Fertility Services market in the U.S. is estimated at US$13.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$31.7 Billion by the year 2030 trailing a CAGR of 19.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.1% and 12.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.3% CAGR.

Global Fertility Services Market - Key Trends and Drivers Summarized

How Are Fertility Services Revolutionizing Reproductive Health and Family Planning?

Fertility services are transforming reproductive health and family planning by offering advanced medical interventions and personalized care to individuals and couples facing challenges in conceiving. With increasing awareness and acceptance of fertility treatments, advancements in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), egg freezing, and genetic screening, are giving hope to millions of people worldwide. Fertility services include a range of treatments that help diagnose and treat infertility, support family planning, and improve reproductive health. These services are becoming essential in the modern landscape of healthcare, allowing individuals and couples to realize their dreams of parenthood despite age, medical conditions, or other factors.

In recent years, the demand for fertility services has grown due to societal changes, such as delayed childbearing, lifestyle factors, and rising infertility rates. Fertility clinics now offer a wide array of services, from fertility assessments and hormonal treatments to cutting-edge ART procedures. The rise of egg freezing, particularly among women who wish to preserve their fertility for future pregnancies, has become a significant trend. This expansion of fertility services is not only empowering individuals to take control of their reproductive health but is also making family planning more accessible and inclusive, especially for same-sex couples, single parents, and those facing reproductive health challenges. As fertility treatments advance and societal acceptance grows, these services are playing a transformative role in how people plan their families.

Why Are Fertility Services Critical for Addressing Reproductive Challenges and Expanding Family Planning Options?

Fertility services are critical for addressing reproductive challenges and expanding family planning options because they offer medical solutions to individuals and couples who may face obstacles in conceiving naturally. With the increasing prevalence of infertility-affecting around 10-15% of couples globally-fertility services provide hope and support by diagnosing and treating underlying conditions that hinder conception. Whether due to age, hormonal imbalances, genetic factors, or lifestyle issues, infertility can be emotionally and physically taxing. Fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and egg or sperm donation enable people to overcome these barriers and achieve successful pregnancies.

Fertility services are also crucial in providing options for those who may not face infertility but are seeking alternatives for family planning. Women who choose to delay childbearing for personal or career reasons can now turn to egg freezing, which preserves their eggs at an optimal time, giving them the flexibility to conceive later in life. Additionally, fertility services offer crucial options for LGBTQ+ individuals and couples, as well as single parents, who may require donor eggs, sperm, or surrogacy to start a family. These services ensure that parenthood is not limited by biological constraints or traditional family structures, offering more inclusive and diverse pathways to having children.

Another key role of fertility services is in addressing medical conditions like polycystic ovary syndrome (PCOS), endometriosis, and male infertility issues such as low sperm count or motility. These conditions often go undiagnosed and untreated, but fertility clinics provide targeted treatments and interventions that increase the chances of conception. Furthermore, advancements in genetic screening and preimplantation genetic testing (PGT) allow for the identification of genetic disorders before pregnancy, ensuring healthier outcomes for both parents and babies. This comprehensive approach to fertility care is helping more people navigate complex reproductive challenges and expand their family-building options in ways that were not possible before.

What Are the Expanding Applications and Innovations in Fertility Services Across Reproductive Health?

The applications and innovations in fertility services are rapidly expanding, driven by breakthroughs in medical technology, genetics, and personalized reproductive care. One of the most significant advancements in fertility services is the rise of in vitro fertilization (IVF), which has revolutionized how couples and individuals approach infertility. IVF involves the fertilization of an egg outside the body, followed by the implantation of the embryo into the uterus. As technology improves, success rates for IVF have increased, making it one of the most effective treatments for infertility. Innovations such as time-lapse imaging and embryo monitoring systems allow embryologists to assess the development of embryos with greater precision, improving the chances of successful implantation and pregnancy.

Egg and sperm freezing technologies have also seen significant improvements, providing more opportunities for fertility preservation. Cryopreservation methods, including vitrification, have made it possible to freeze eggs and sperm with higher survival rates, offering individuals the flexibility to delay parenthood. This is particularly important for cancer patients who may face fertility loss due to chemotherapy, as well as women who want to preserve their fertility for personal or professional reasons. Additionally, advancements in sperm extraction techniques have provided solutions for men with low sperm counts or other fertility issues, allowing them to conceive through assisted reproductive technologies.

Another groundbreaking innovation in fertility services is preimplantation genetic testing (PGT), which allows for the genetic screening of embryos before implantation. PGT can detect chromosomal abnormalities or genetic disorders such as cystic fibrosis, sickle cell anemia, and Huntington’s disease, ensuring that only healthy embryos are transferred during IVF. This technology not only increases the chances of a successful pregnancy but also reduces the risk of miscarriage and genetic diseases in the child. Genetic counseling is now an integral part of fertility services, allowing couples to make informed decisions about their reproductive options based on their genetic makeup.

In addition to these technological advancements, fertility services are expanding to include a more holistic approach to reproductive health. Clinics are increasingly offering support services such as fertility coaching, nutritional guidance, mental health counseling, and acupuncture, recognizing the importance of addressing the emotional, physical, and psychological aspects of fertility treatment. Fertility clinics are also embracing digital health tools, with telemedicine consultations, fertility tracking apps, and remote monitoring becoming more common. This shift toward patient-centered care is helping individuals navigate the complex fertility journey with greater support and convenience.

Another area of innovation in fertility services is the growing use of artificial intelligence (AI) and machine learning in fertility treatments. AI-powered systems are being used to analyze large datasets of patient information, embryo development, and treatment outcomes, helping doctors make more accurate decisions about fertility treatment plans. For example, AI can be used to predict the success rates of IVF cycles based on patient history, genetics, and embryo quality, allowing for more personalized and effective treatment strategies. These innovations are making fertility treatments more efficient, accessible, and successful, opening up new possibilities for individuals and couples seeking to build families.

What Factors Are Driving the Growth of the Fertility Services Market?

Several key factors are driving the growth of the fertility services market, including the rising prevalence of infertility, delayed childbearing, advancements in reproductive technologies, and increasing societal acceptance of fertility treatments. One of the primary drivers is the growing global incidence of infertility, which is affecting both men and women. Factors such as lifestyle changes, environmental pollutants, stress, and medical conditions like obesity and polycystic ovary syndrome (PCOS) are contributing to rising infertility rates. As more people face challenges in conceiving naturally, the demand for fertility services continues to rise, with treatments like IVF, IUI, and fertility preservation becoming more commonplace.

Another significant factor contributing to the growth of the fertility services market is the trend toward delayed childbearing. With more women prioritizing their careers, education, and personal goals, many are choosing to have children later in life. However, age is a critical factor in fertility, particularly for women, as fertility declines with age. Fertility services, including egg freezing and IVF, provide solutions for women who wish to preserve their fertility and conceive later in life, leading to increased demand for these services. Additionally, with the rise in second marriages and blended families, fertility services are being used by older individuals or couples who wish to have children together, further driving market growth.

Advancements in reproductive technologies are also playing a crucial role in the expansion of the fertility services market. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and cryopreservation techniques have improved the success rates of fertility treatments, making them more appealing to individuals and couples seeking reproductive assistance. The integration of AI and machine learning in fertility clinics is further enhancing treatment outcomes by providing more personalized care and optimizing treatment strategies. These technological advancements are making fertility treatments more effective and accessible, encouraging more people to explore fertility options.

The growing societal acceptance of fertility treatments is another major factor driving market growth. Fertility treatments, once considered taboo or stigmatized, are now widely accepted and embraced, especially in developed countries. Public figures and celebrities openly discussing their fertility journeys have helped to reduce the stigma around infertility, encouraging more people to seek fertility services. Moreover, legal and social advancements, such as the recognition of same-sex marriages and the availability of surrogacy and donor programs, are providing new pathways for LGBTQ+ individuals and single parents to build families. As these treatments become more accessible and normalized, the fertility services market continues to expand.

Increasing government support and healthcare coverage for fertility treatments are also driving the growth of the market. In many countries, insurance companies and healthcare systems are beginning to cover a portion of the costs associated with fertility treatments like IVF, making them more affordable for a broader population. Government initiatives that promote reproductive health and provide financial assistance for fertility treatments are also helping to increase access to these services. In regions where fertility rates are declining, governments are investing in fertility treatments as part of national efforts to boost population growth, further contributing to the expansion of the market.

In conclusion, the fertility services market is poised for significant growth as more individuals and couples seek reproductive assistance to overcome infertility, delay parenthood, or pursue non-traditional family-building options. With advancements in reproductive technologies, growing societal acceptance, and increasing access to fertility services, the industry is set to play an even larger role in helping people realize their dreams of parenthood. As fertility treatments continue to evolve and improve, they will provide more inclusive, effective, and personalized care, revolutionizing the landscape of reproductive health and family planning worldwide.

SCOPE OF STUDY:

The report analyzes the Fertility Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor, Frozen Donor); End-Use (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Fertility Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Infertility Rates Driving Demand for Fertility Services
    • Advancements in Assisted Reproductive Technologies (ART) Enhancing Success Rates
    • Growing Acceptance and Legalization of IVF and Surrogacy Across Different Regions
    • Market Trends Toward Personalized Treatment Plans Based on Genetic Testing
    • Future Directions: Integration of AI and Machine Learning in Fertility Treatment Protocols
    • Technological Innovations in Embryo Screening and Preservation Techniques
    • Global Increase in Same-Sex Couples and Single Parents Using Fertility Services
    • Regulatory and Ethical Considerations in Egg and Sperm Donation
    • Development of Mobile Apps and Online Platforms for Fertility Consultation and Management
    • Market Response to Growing Trends in Egg Freezing for Career Planning
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Services Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Egg & Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Clinical Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제